You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers stay ahead of the curve as well as links to the week’s most important news. We no longer send these by email as we did in the past, but we post this and all of the newsletters on our website here.
Friends,
This week, there was some exciting news regarding M&A in the cannabis sector: Verano is buying the Arizona operations and part of the Virginia operations of Cannabist. We thought M&A for MSOs had died when Cannabist and Cresco Labs terminated their pending merger last July.
M&A in the cannabis industry is challenging due to the fact that it is state-regulated. Some states, like Illinois, Maryland, New Jersey and Pennsylvania, limit the number of stores one operator can have. Others, like Massachusetts, limit the size of the production facilities. Cresco and Cannabist, then Columbia Care, had announced their merger initially in March 2022, and they were working on selling assets to overcome the regulatory barriers. They had announced a potential sale of some to Sean Combs in late 2022.
The deal with Verano will give Cannabist $105 million in cash, debt and stock. $15 million in cash will pay for the two dispensaries, one cultivation facility and one production facility in Arizona. This fits with what the new management team has communicated to investors in terms of focusing on strong positions and potentially exiting more states that don’t impact the financials.
$90 million will be paid for the Virginia operations, consisting of $20 million cash, $40 million in stock and $30 million of a promissory note. Cannabist did not issue a press release, and the Verano release mentioned but did not emphasize that Virginia will still be a market for Cannabist, which had 2 of the 5 licenses.
The state’s five regions are geographical, and Columbia Care was appointed for HSA 5, with Virginia Beach, Norfolk, Chesapeake, Newport News, Hampton and Portsmouth. These are the assets being sold to Verano. Green Leaf Medical, which the company acquired in June 2021, won HSA 4, with 27 counties that includes the city of Richmond. Columbia Care paid $240 million for Green Leaf, and fortunately $195 million was in stock.
Cannabist has increased a bit since the deal with Verano was announced, but it is still down 45.7% so far in 2024. Since the deal with Cresco was terminated, it has declined almost 42% with Cresco marginally higher:
Since the deal was first announced, it has declined 92%, while Cresco has declined 74%. I think Cannabist is a very attractively valued MSO, trading at less than 4X enterprise value to projected adjusted EBITDA for 2025. This deal will improve its financial position.
What was most interesting to me is that the price they are getting for just a small portion of their overall business exceeded the entire market cap at the time it was announced. While I like the deal, I did reduce my model portfolio position at 420 Investor after the big bounce on Monday. It is not in the index but still a relatively large position. With rescheduling likely ahead, almost all of the MSOs should do better if that happens. I think Cannabist is likely to do a lot better than its peers.
New Cannabis Ventures publishes curated articles as well as exclusive news. Here is some of the most important content from this week:
Exclusives
Ancillary Cannabis Stocks Lead in July
The Global Cannabis Stock Index Jumps in July
Financial
Hawthorne Gardening Sales Drop 28%
Tilray Brands Q4 Cannabis Business Lifts 13%
Mergers and Acquisitions
Cannabist to Sell Arizona and Virginia Operations to Verano
To get real-time updates download our free mobile app for Android or Apple devices, like our Facebook page, or follow Alan on Twitter. Share and discover industry news with like-minded people on the largest cannabis investor and entrepreneur group on LinkedIn.
Use the suite of professionally managed NCV Cannabis Stock Indices to monitor the performance of publicly-traded cannabis companies within the day or over longer time-frames. In addition to the comprehensive Global Cannabis Stock Index, we offer the Canadian Cannabis LP Index, the American Cannabis Operator Index and the Ancillary Cannabis Index.
View the Public Cannabis Company Revenue & Income Tracker, which ranks the top revenue producing cannabis stocks.
Stay on top of some of the most important communications from public companies by viewing upcoming cannabis investor earnings conference calls.
Discover upcoming new listings with the curated Cannabis Stock IPOs and New Issues Tracker.
Sincerely,
Alan
